Severe COVID-19 is characterised by inflammation and immature myeloid cells early in disease progression.
Heliyon
; 8(4): e09230, 2022 Apr.
Article
in En
| MEDLINE
| ID: mdl-35386227
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Heliyon
Year:
2022
Document type:
Article
Affiliation country:
Irlanda
Country of publication:
Reino Unido